2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine

C123H159N9O14 — CID 91067211

IUPAC2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine
SMILESCN1CCC(CCCC2CCN(C)CC2)CC1.COc1ccc(N(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1.COc1ccc(N(c2ccc(OC)cc2)c2ccc(OCCOc3ccc(N(c4ccc(OC)cc4)c4ccc(OC)cc4)cc3)cc2)cc1.COc1ccc(OCCCN2CC(C)N(CCCOc3ccc(C)cc3)CC2C)cc1.Cc1ccc(OC(C)C(=O)NCCCN2CCCCC2)c(C)c1
InChIInChI=1S/C42H40N2O6.C26H38N2O3.C21H21NO3.C19H30N2O2.C15H30N2/c1-45-37-17-5-31(6-18-37)43(32-7-19-38(46-2)20-8-32)35-13-25-41(26-14-35)49-29-30-50-42-27-15-36(16-28-42)44(33-9-21-39(47-3)22-10-33)34-11-23-40(48-4)24-12-34;1-21-7-9-25(10-8-21)30-17-5-15-27-19-23(3)28(20-22(27)2)16-6-18-31-26-13-11-24(29-4)12-14-26;1-23-19-10-4-16(5-11-19)22(17-6-12-20(24-2)13-7-17)18-8-14-21(25-3)15-9-18;1-15-8-9-18(16(2)14-15)23-17(3)19(22)20-10-7-13-21-11-5-4-6-12-21;1-16-10-6-14(7-11-16)4-3-5-15-8-12-17(2)13-9-15/h5-28H,29-30H2,1-4H3;7-14,22-23H,5-6,15-20H2,1-4H3;4-15H,1-3H3;8-9,14,17H,4-7,10-13H2,1-3H3,(H,20,22);14-15H,3-13H2,1-2H3
InChIKeyGFKVIUQJTAYFRP-UHFFFAOYSA-N
MW1987.67 g/mol
LogP25.84
Rot. Bonds43

About 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine

2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine (PubChem CID 91067211) has the molecular formula C123H159N9O14 and a molecular weight of 1987.67 g/mol. Its IUPAC name is 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine.

Molecular Properties

Compound Name2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine
PubChem CID91067211
Molecular FormulaC123H159N9O14
Molecular Weight1987.67 g/mol
Exact Mass1986.20
IUPAC Name2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine
SMILESCN1CCC(CCCC2CCN(C)CC2)CC1.COc1ccc(N(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1.COc1ccc(N(c2ccc(OC)cc2)c2ccc(OCCOc3ccc(N(c4ccc(OC)cc4)c4ccc(OC)cc4)cc3)cc2)cc1.COc1ccc(OCCCN2CC(C)N(CCCOc3ccc(C)cc3)CC2C)cc1.Cc1ccc(OC(C)C(=O)NCCCN2CCCCC2)c(C)c1
InChIInChI=1S/C42H40N2O6.C26H38N2O3.C21H21NO3.C19H30N2O2.C15H30N2/c1-45-37-17-5-31(6-18-37)43(32-7-19-38(46-2)20-8-32)35-13-25-41(26-14-35)49-29-30-50-42-27-15-36(16-28-42)44(33-9-21-39(47-3)22-10-33)34-11-23-40(48-4)24-12-34;1-21-7-9-25(10-8-21)30-17-5-15-27-19-23(3)28(20-22(27)2)16-6-18-31-26-13-11-24(29-4)12-14-26;1-23-19-10-4-16(5-11-19)22(17-6-12-20(24-2)13-7-17)18-8-14-21(25-3)15-9-18;1-15-8-9-18(16(2)14-15)23-17(3)19(22)20-10-7-13-21-11-5-4-6-12-21;1-16-10-6-14(7-11-16)4-3-5-15-8-12-17(2)13-9-15/h5-28H,29-30H2,1-4H3;7-14,22-23H,5-6,15-20H2,1-4H3;4-15H,1-3H3;8-9,14,17H,4-7,10-13H2,1-3H3,(H,20,22);14-15H,3-13H2,1-2H3
InChIKeyGFKVIUQJTAYFRP-UHFFFAOYSA-N
XLogP25.84
TPSA175.01 Ų
H-Bond Donors1
H-Bond Acceptors22
Rotatable Bonds43
Heavy Atoms146
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001987.67
LogP ≤ 525.84
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine?
The IUPAC name of 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine (CID 91067211) is 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine.
What is the SMILES notation for 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine?
The canonical SMILES for 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine is CN1CCC(CCCC2CCN(C)CC2)CC1.COc1ccc(N(c2ccc(OC)cc2)c2ccc(OC)cc2)cc1.COc1ccc(N(c2ccc(OC)cc2)c2ccc(OCCOc3ccc(N(c4ccc(OC)cc4)c4ccc(OC)cc4)cc3)cc2)cc1.COc1ccc(OCCCN2CC(C)N(CCCOc3ccc(C)cc3)CC2C)cc1.Cc1ccc(OC(C)C(=O)NCCCN2CCCCC2)c(C)c1.
What is the InChIKey of 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine?
The InChIKey is GFKVIUQJTAYFRP-UHFFFAOYSA-N. The full InChI is InChI=1S/C42H40N2O6.C26H38N2O3.C21H21NO3.C19H30N2O2.C15H30N2/c1-45-37-17-5-31(6-18-37)43(32-7-19-38(46-2)20-8-32)35-13-25-41(26-14-35)49-29-30-50-42-27-15-36(16-28-42)44(33-9-21-39(47-3)22-10-33)34-11-23-40(48-4)24-12-34;1-21-7-9-25(10-8-21)30-17-5-15-27-19-23(3)28(20-22(27)2)16-6-18-31-26-13-11-24(29-4)12-14-26;1-23-19-10-4-16(5-11-19)22(17-6-12-20(24-2)13-7-17)18-8-14-21(25-3)15-9-18;1-15-8-9-18(16(2)14-15)23-17(3)19(22)20-10-7-13-21-11-5-4-6-12-21;1-16-10-6-14(7-11-16)4-3-5-15-8-12-17(2)13-9-15/h5-28H,29-30H2,1-4H3;7-14,22-23H,5-6,15-20H2,1-4H3;4-15H,1-3H3;8-9,14,17H,4-7,10-13H2,1-3H3,(H,20,22);14-15H,3-13H2,1-2H3.
What are the key properties of 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine?
2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine has a molecular weight of 1987.67 g/mol, XLogP of 25.84, 43 rotatable bonds, 1 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(2,4-dimethylphenoxy)-N-(3-piperidin-1-ylpropyl)propanamide;4-methoxy-N,N-bis(4-methoxyphenyl)aniline;4-methoxy-N-[4-[2-[4-(4-methoxy-N-(4-methoxyphenyl)anilino)phenoxy]ethoxy]phenyl]-N-(4-methoxyphenyl)aniline;1-[3-(4-methoxyphenoxy)propyl]-2,5-dimethyl-4-[3-(4-methylphenoxy)propyl]piperazine;1-methyl-4-[3-(1-methylpiperidin-4-yl)propyl]piperidine is sourced from PubChem (CID 91067211), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).